Feisst C - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Suppression of receptor-mediated Ca2+ mobilization and functional leukocyte responses by hyperforin.

Feisst C, Werz O. Feisst C, et al. Biochem Pharmacol. 2004 Apr 15;67(8):1531-9. doi: 10.1016/j.bcp.2003.12.020. Biochem Pharmacol. 2004. PMID: 15041470

Hyperforin induces Ca(2+)-independent arachidonic acid release in human platelets by facilitating cytosolic phospholipase A(2) activation through select phospholipid interactions.

Hoffmann M, Lopez JJ, Pergola C, Feisst C, Pawelczik S, Jakobsson PJ, Sorg BL, Glaubitz C, Steinhilber D, Werz O. Hoffmann M, et al. Among authors: feisst c. Biochim Biophys Acta. 2010 Apr;1801(4):462-72. doi: 10.1016/j.bbalip.2009.12.007. Epub 2009 Dec 28. Biochim Biophys Acta. 2010. PMID: 20044029

Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo.

Feisst C, Pergola C, Rakonjac M, Rossi A, Koeberle A, Dodt G, Hoffmann M, Hoernig C, Fischer L, Steinhilber D, Franke L, Schneider G, Rådmark O, Sautebin L, Werz O. Feisst C, et al. Cell Mol Life Sci. 2009 Aug;66(16):2759-71. doi: 10.1007/s00018-009-0078-3. Epub 2009 Jul 5. Cell Mol Life Sci. 2009. PMID: 19579006

Evaluation of hyperforin analogues for inhibition of 5-lipoxygenase.

Feisst C, Albert D, Verotta L, Werz O. Feisst C, et al. Med Chem. 2005 May;1(3):287-91. doi: 10.2174/1573406053765503. Med Chem. 2005. PMID: 16787324

Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid.

Poeckel D, Tausch L, Altmann A, Feisst C, Klinkhardt U, Graff J, Harder S, Werz O. Poeckel D, et al. Among authors: feisst c. Br J Pharmacol. 2005 Oct;146(4):514-24. doi: 10.1038/sj.bjp.0706366. Br J Pharmacol. 2005. PMID: 16086030 Free PMC article.

Identification of molecular targets of the oligomeric nonprenylated acylphloroglucinols from Myrtus communis and their implication as anti-inflammatory compounds.

Feisst C, Franke L, Appendino G, Werz O. Feisst C, et al. J Pharmacol Exp Ther. 2005 Oct;315(1):389-96. doi: 10.1124/jpet.105.090720. Epub 2005 Jul 13. J Pharmacol Exp Ther. 2005. PMID: 16014754

The aminosteroid phospholipase C antagonist U-73122 (1-[6-[[17-beta-3-methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione) potently inhibits human 5-lipoxygenase in vivo and in vitro.

Feisst C, Albert D, Steinhilber D, Werz O. Feisst C, et al. Mol Pharmacol. 2005 May;67(5):1751-7. doi: 10.1124/mol.105.011007. Epub 2005 Jan 31. Mol Pharmacol. 2005. PMID: 15684042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results